Syncope, a transient loss of consciousness (T-LOC) due to cerebral hypoperfusion, presents a diagnostic challenge for healthcare professionals. Despite its high prevalence, the etiological diagnosis remains elusive in approximately 40% of cases. This article aims to provide a comprehensive approach to better understand and manage syncope.
Syncope can be broadly classified into three categories: reflex (neurally mediated), orthostatic hypotension, and cardiac syncope. Reflex syncope includes vasovagal, situational, and carotid sinus syncope. Orthostatic hypotension is associated with autonomic failure, medications, and volume depletion. Cardiac syncope may be due to arrhythmias or structural heart diseases.
A detailed history and physical examination are crucial in the evaluation of syncope. The history should focus on the prodromal symptoms, triggers, and post-event period. Physical examination should include orthostatic blood pressure measurements and cardiac evaluation. In selected cases, further diagnostic tests such as electrocardiogram, echocardiography, tilt table testing, and loop recorder implantation may be warranted.
Management primarily involves treating the underlying cause. In reflex syncope, patient education, reassurance, and lifestyle modifications are often sufficient. Pharmacological treatment may be considered in recurrent cases. Patients with orthostatic hypotension may benefit from volume expansion, compression stockings, and medications. Cardiac syncope requires prompt referral to a cardiologist for further evaluation and treatment.
Understanding the complex pathophysiology of syncope is key to its effective management. A systematic approach, starting from a thorough history and physical examination to appropriate diagnostic testing and management, can help demystify this common yet often perplexing clinical entity. By adopting this comprehensive approach, healthcare professionals can ensure optimal care for patients presenting with syncope.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation